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Summary DNA-synthetizing lymphocytes were identified in the lymph nodes regional and more distal to the
site of developing P-815 tumours by incorporation of [3H]-thymidine followed by autoradiography of lymph
node sections. It appeared that not only T but also B cell areas of draining and to a lesser extent of distal
lymph nodes were stimulated by the growing tumour. This result was unexpected since neither humoral nor
tumour cell-bound antibody could be identified so far as a functional correlate of B cell stimulation.
In general the proliferative response of lymphocytes followed a biphasic pattern with an early peak of
reactivity on days 2-3 and a second peak around day 12-15 after tumour cell inoculation. In the draining
(axillary) lymph node the second peak of reactivity was suppressed, possibly as a consequence of metastatic
tumour cells in this node when tumour cells were inoculated in the flank.
The pattern of lymphocyte stimulation revealed larger individual variations after tumour cell inoculation in
the flank than the foot pad. These results were associated with a slower and less regular drainage of carbon
particles from the flank to the axillary and exceptionally the brachial lymph node than from the foot pad to
the popliteal node after injection of India ink.
The P-815 mastocytoma is a highly malignant and
readily metastasizing, but weakly immunogenic
murine tumour of DBA/2 origin (Dunn & Potter,
1957). In syngeneic hosts the malignant nature of
the tumour manifests itself by rapid and progressive
growth, leading to the death of the recipient,
following the i.p. or s.c. injection of as few as 102
P-815 cells. In contrast, up to 105 viable cells fail to
develop into detectable tumours upon inoculation
into the hind leg foot pads of DBA/2 mice. Yet
another pattern of tumour development may be
observed when P-815 cells are injected i.d. into the
flanks: local tumour growth proceeds up to day 10
after inoculation, followed by a phase of more or
less pronounced spontaneous regression which in
most cases changes to progression and ends in the
death of the host; an occasional animal completes
regression, survives and exhibits relative immunity
against subsequent challenge with live tumour cells.
Regardless of the ultimate outcome, a T cell-
dependent cytotoxicity could be demonstrated
during the regression phase which was pronounced
in regional lymph nodes but marginal in the spleen.
Therefore, an immunogenic effect of the highly
malignant P-815 cells may likewise be demonstrated
under conditions less favorable to the host than
those of the foot pad model (Bertschmann et al.,
1979). The present study was aimed at a better
understanding of lymphocyte kinetics in lymph
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nodes draining the site of P-815 inoculation using
the foot pad as compared to the i.d. route. Separate
analyses of the diffuse cortical ("T dependent") and
the medullary zone ("B cell area") of local lymph
nodes as a function of time following tumour cell
injection in both cases revealed a T cell reaction,
accompanied by a marked stimulation of the B cell
system. This result was\surprising since neither with
the P-815 nor with several other syngeneic tumour
systems has tumour-specific humoral antibody
been detected so far.
Materials and methods
Animals
Female DBA/2 mice were purchased from GI.
Bomholtgard, Ltd., Ry, Denmark and were used
when they were 23-25g body wt (3-5 months of
age).
Tumour cells
P-815 mastocytoma cells, banked in liquid nitrogen
were thawed, washed in HBSS and injected i.p. into
syngeneic DBA/2 mice. One week later, i.e. when a
total number of - 3 x 108 cells/animal was reached,
tumour cells were harvested from the peritoneal
cavity, washed and suspended in HBSS for
inoculation into experimental animals.
Tumour cell injection
Tumour cells were inoculated essentially as
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described before (Bertschmann et al., 1979):
Animals were anaesthetized with Nembutal
(50 gg-1 body wt) and received 10 lul HBSS
containing 105 or 104 tumour cells in the right foot
pad or i.d. in the right anteriodorsal part of the
flank, respectively; the injection was monitored
under a stereomicroscope. Local tumour growth in
the flanks was registered by caliper measurements
of tumour diameters three times per week; local
tumour growth was generally not observed
following tumour cell inoculation into foot pads.
Labelling in vivo with [3I]-dT and preparation of
lymph node cells
At various times after the injection of tumour cells
or HBSS alone groups of 5 mice each received an
i.v. injection containing 1 juCi of [3H]-thymidine
([3H]-dT) (Sp. act. 24CimM-1, Amersham,
England) in PBS per g body wt and were killed by
ether overdose 30min later.
Popliteal, axillary (located on the pectoral
muscle) and brachial (cocooned to the triceps
muscle) lymph nodes were removed from the ipsi-
lateral (=draining the tumour inoculation site) and
the left (=contralateral) side of the body, fixed in
4% formaldehyde in PBS, dehydrated and
embedded in paraplast. Sections (4Mum) were
prepared to obtain maximum cross-sectional
surfaces ofindividual nodes.
Autoradiography
Sections used for autoradiography were processed
as previously described (Biirki et al., 1974). Briefly,
lymph node sections were dipped in NBT-2 photo-
graphic emulsion (Kodak SH, Lausanne) and
exposed in sealed boxes at 40 for 3-8 weeks.
Developed and fixed autoradiographs were stained
through the film with nuclear fast red. One
representative section per lymph node was used for
histometry.
Evaluation ofautoradiography and histometry
For each lymph node section of 5 animals per
condition and time interval, areas occupied by the
diffuse cortex ("paracortex") and the medulla were
assessed by planimetry on a MOP/AMO 1 unit
(Kontron AG, Zurich). Cell numbers per unit cross-
sectioned area (cellularity) and labelling indices of
lymphoid cells in the paracortex as well as of
lymphoid and plasmacytoid cells in the medullary
cords were registered. Thus, absolute numbers of
labelled cells per zone of lymph node cross sections
could be calculated (for details of methodology see
Burki et al., 1974). Individual values are given as
mean + s.e. Differences between groups were
analyzed by Wilcoxon rank test. Care was taken to
identify foci of and, where possible, single meta-
static P-815 tumour cells in lymph node sinuses and
parenchyma.
Lymphatic drainage ofinjection site
Anaesthetized Swiss albino mice were injected into
the left hind foot pad and i.d. into the right shaved
flank with a 1:10 dilution of India ink in HBSS.
Between 30min and 12 days groups of animals
were sacrificed, the axillary, brachial and popliteal
nodes removed, fixed in 4% formaldehyde in PBS
and observed in transmitted plus incident light.
Sequence ofexperiments
In a first approach proliferative patterns of
lymphocytes in the popliteal node were studied
after tumour cell injection into the hind foot pad
since a considerable amount of data was already
available for corresponding stimulation with tetanus
toxoid (Biirki et al., 1974). In a second series of
experiments the stimulation by proliferating tumour
cells of lymphocytes in the axillary and brachial
nodes was investigated and a possible correlation
with tumour regression and progression studied. In
the first series of experiments, groups of mice
injected with HBSS alone were followed during the
whole experimental period. As no stimulation was
registered after this treatment, these controls were
omitted in the second series ofexperiments.
Results
Tumour cell injection into the right hindfoot pad
No tumour growth was detectable after the
injection of 105 tumour cells during the observation
period of 28 days in a total of 21 experimental
animals. In a further group of 5 animals which
were injected at the same time but observed over a
period of 90 days, one single animal developed an
eventually fatal tumour by Day 40.
Proliferative pattern in the popliteal lymph nodes
The absolute numbers of initially labelled lympho-
cytes per cross-sectioned deep cortex of the draining
lymph node as a function of time after tumour cell
injection are plotted in Figure la.
While the number of labelled lymphoid cells did
not change appreciable in animals given HBSS
alone, a definite increase in the proliferative activity
of lymphocytes in the deep cortical area was noted
following inoculation of tumour cells. This increase
was observed on Day 1 already and reached an
early peak on Day 3, followed by a second peak on
Day 14, which was significantly above control levelsPROLIFERATION OF LYMPHOCYTES DURING TUMOUR DEVELOPMENT 479
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Figure 1 Absolute number of [3H]-dT-incorporating lymphoid cells per cross-section of popliteal lymph node
as a function of time after the inoculation of 105 P-815 tumour cells into the ipsilateral hind foot pad. (a)
paracortical (T cell-dependent) area (b) medullary (B cell-dependent) area * 0* P-815-cells 0 --- 0 HBSS
alone.
(P<O.O1). By Day 28 the proliferative activity in
this lymph node was again similar to that in
controls.
A similar sequence in time of proliferation was
observed in the lymphoplasmacytoid cells of the
medullary zone of tumour bearing mice (Figure
lb): A marked increase in the absolute number of
initially labelled lymphoid cells of the medulla was
observed already by Days 2-3, again significantly
different from values obtained in controls
(P<0.01). After this short wave of increased DNA-
synthetic activity the absolute number of labelled
medullary cells dropped sharply on Days 4 to 6 to
a level significantly lower than on Day 2 (P<0.05),
and increased again by Day 14. At this time point
labelled cells were predominantly lymphoplasma-
cytoid and the absolute number of DNA
synthesizing cells in the medulla was almost 3 times
higher than on Days 2 to 3. Control levels were
again reached by Day 28.
The time course of changes in proliferative
activity of lymphocytes in the deep cortical and
medullary zones of contralateral popliteal lymph
nodes was essentially similar to those observed in
lymph nodes draining the tumour inoculation side.
The values obtained, were, however, at no time
point significantly different from control values.
Tumour cell injection into the right.flank
The development of local tumours following P-815
inoculation into the right flank is presented in
Figure 2: Neoplasms usually reached a measurable
size just before Day 6 and after a steady increase in
volume, regression - either temporary or longer
lasting - set in after Days 9-12. It is evident from
Figure 2 that tumour development was quite
uniform in all mice up to Day 9 while considerable
variation in individual patterns of tumour develop-
ment was observed at later time intervals.
Proliferative pattern in axillary and brachial lymph
nodes
Absolute numbers of initially labelled lymphocytes
per cross-sectioned deep cortex are plotted as a
function of time in Figure 3a and b for the axillary
and brachial nodes, respectively. In general, the
course of changes observed in draining and contra-
lateral lymph nodes were comparable during the
first 6-9 days: After an initial increase on Days 1
and 2, average values dropped between Days 3-6.
In the axillary node of the ipsilateral side there was
a further drop in the number of labelled cells while
[3H]-dT incorporation in the contralateral axillary
node varied. In contrast a pronounced peak in the
number of labelled cells was observed on Day 12 in
the brachial node draining the tumour site, which
was significantly higher than both control values
(P<0.01) and the less pronounced peak in the
contralateral brachial node (P<0.05).
Animals which were killed on Day 19 showed
levels of stimulation in both the axillary and the
brachial node which did not significantly deviate
from the control level. The data obtained for
stimulation of the medullary (B cell-dependent)
zone of the axillary nodes of the tumour side and
contralateral side are similar (Figure 4a). A
pronounced peak of [3H]-dT incorporation on Day
2 is followed by a decline on Day 4. Values
obtained at later stages of tumour development are
slightly but significantly elevated with a tendency to
reach control levels by Day 19. Values for Days 9
to 12 obtained from the node draining the tumour
site are based on only two samples each, since in
other preparations the presence of large numbers of
metastatic tumour cells precluded a meaningful
evaluation.
In branchial lymph nodes (Figure 4b) the number
of initially labelled cells started to increase on Day
4 and remained above control levels up to Day 4
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Figure 2 Tumour growth as a function of time after the i.d. inoculation of 104 P-815 tumour cells in the
flank. Individual growth curves indicated.
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Figure 3 Absolute number of [3H]-dT-incorporating lymphoid cells per cross sectioned paracortical area of
axillary (a) and brachial (b) lymph nodes of ipsilateral and contralateral side after the injection of 104 P-815
tumour cells into the flank. * * ipsilateral node 0 ---0 contralateral node.
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Figure 4 Absolute number of [3H]-dT-incorporating lymphoid cells per cross sectioned medullary area of
axillary (a) and brachial (b) lymph node of ipsilateral and contralateral side after the injection of 104 P-815
tumour cells into the flank. * * ipsilateral node 0 --- 0 contralateral node.
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and 12. The peak value on Day 12 registered for
the node draining the tumour site is significantly
higher than the control level (P<0.05) but not
significantly different from the one of the contra-
lateral node.
Occurrence ofmetastases
After the injection of tumour cells into the hind
foot pad, spread the popliteal lymph node was not
observed. However, since only a single cross section
per lymph node was examined per time interval,
metastases may have been missed.
As is evident from Table I, metastasizing P-815
cells were frequently observed following inoculation
into the flanks. They were seen either in the form
of small clusters or diffuse tumour tissue in the
axillary lymph node draining the tumour site. The
brachial nodes on the side of the tumour were less
frequently involved and diffuse growth was only
observed at later stages (from Day 15 on). Involve-
ment of lymph nodes of the contralateral side was
noted occasionally.
Lymphatic drainage
As differences were observed in the reaction of
draining lymph nodes after injection of tumour cells
into the foot pad or into the flank, the pattern and
extent of lymphatic drainage from these sites to the
lymph nodes, which were examined in the tumour
model, were studied. A series of outbred Swiss
albino mice was given an injection of India ink
either into the foot pad or i.d. into the flank.
Spread of carbon particles to popliteal as well as to
axillary and brachial lymph nodes was judged with
the help of a stereoscopic microscope. Under these
conditions, which are comparable to those used for
tumour cell inoculation, total blackening of
popliteal nodes was observed within minutes after
India ink injection into the foot pads. In contrast,
drainage from the injection site in the flank to
axillary and brachial nodes of the tumour side was
much slower, less intense and less regular: Sectorial
blackening of axillary lymph nodes was observed
from Day 6 on in most cases, while it was rare in
brachial nodes. Carbon particles were never found
in contralateral lymph nodes by the macroscopic
method used.
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Discussion
Ample evidence exists to demonstrate the
importance of regional lymph nodes as sites of
immune reactions against transplanted normal
and neoplastic tissue (Canty & Wunderlich, 1971,
Fisher et al., 1974, Galili et al., 1980, Matossian-
Rogers & Rogers, 1982). In additiona, several
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reports attest to the appearance of distinct morpho-
logical changes in accordance with ongoing immune
reactions (Fisher et al., 1974, Jones et al., 1978;
Check et al., 1980). The emergence and
disappearance in vivo of T cell-mediated cyto-
toxicity under syngeneic conditions as measured in
cell suspensions obtained from draining lymph
nodes in the course of regional growth of i.d.
injected P-815 cells may be cited as adding
functional meaning to these observations
(Bertschmann et al., 1979).
When we compare the present data concerning
proliferative patterns in tumour bearing animals of
lymphocytes in medullary and paracortical areas of
regional and more distant lymph nodes, it appears
that there is no simple correlation between lympho-
cyte proliferation and cytotoxicity as measured
under in vitro conditions. A biphasic pattern of
[3H]-dT incorporation was noted in lymphocytes of
lymph nodes regional to both foot pad and flank
injection of P-815 cells. There was however no
functional correlate with the early peak of
stimulation on Days 2-3 i.e. at that time no
cytotoxicity could be observed in the draining
axillary lymph nodes. The pattern of syngeneic
stimulation but not of syngeneic cytotoxic reactivity
resembled in this respect the biphasic cytotoxic
reactivity of lymphocytes from the node draining
the site of an allogeneic skin transplant as described
by Canty & Wunderlich (1971). Our results also
contrast in some way with those of Jones et al.,
1978) who were able to detect not only proliferation
but also cytotoxicity as early as 4 days after i.m.
implantation of syngeneic rat hepatoma cells. One
should remember, however, that the immuno-
genicity of the P-815 tumour is extremely weak
compared to many other syngeneic and, in
particular, allogeneic model systems. The prolifer-
ation of T-cells with helper function during the first
wave of reactivity under syngeneic conditions may
be a further possibility to explain the absence of
cytotoxicity during this early period of tumour cell
proliferation.
While proliferative changes in regional lymph
nodes followed a similar pattern after P-815 cell
inoculation in foot pads and flanks, individual
variations and differences were considerably more
pronounced following stimulation by the i.d.
injection of cells into the flank. The spread of
carbon particles after India ink injection via the
two routes used in the experiment was remarkably
different: Drainage of particulate matter from the
foot pad to the popliteal node was fast and deposits
were uniformly dispersed (total blackening after
1 h). By comparison carbon drainage from the flank
was slow (distinct blackening beyond Day 6 only)
and drainage was not restricted to the axillary node
but in some individuals also involved the brachial
node. Blackening of both ipsilateral lymph nodes
was sectorial. Involvement of the contralateral
nodes was not observed when judged macro-
scopically. Taken together, spread of particles after
injection into the flank according to the method
used in the present study followed a more
complicated and individually variable pattern which
possibly involved additional lymph nodes not
included in the present study. Injection into the
foot pad resulted in a more uniform distribution of
particulate material. These differences, at least in
part, may explain the differences in variability after
the two injection routes.
Metastatic dissemination of tumour cells was
rarely observed after injection into the foot pads
but occurred frequently at various time intervals
during tumour development in the flank. This
spread was variable, occasionally also involving the
contralateral lymph nodes (Table I) and may
further illustrate the less defined drainage situation
in the flank. It is obvious, however, that spread via
the lymphatics is by no means the only way of
metastatic seeding.
Since T cells appear to be principal effectors of
cytotoxicity in many tumour systems and were
identified as effectors of cytolysis against our P-815
line as well (Bertschmann et al., 1970) the finding
of changes in the number of proliferating lympho-
cytes in T-dependent areas of regional lymph nodes
was not surprising. While the early peak of T cell
proliferation did not correlate in time with in vitro
cytotoxicity, the second proliferative peak did.
However, cytotoxic activity on Days 10-12 was
limited to axillary lymph nodes of the ipsilateral
side (Bertschmann et al., 1979) which at this time
showed little or no lymphocyte proliferation in the
diffuse cortex. The ipsilateral brachial lymph nodes
exhibited no cytotoxicity in spite of a pronounced
T cell proliferation around Days 9-12. However,
decrease of proliferative reactions and increased
cytotoxicity may not represent mutually exclusive
phenomena since proliferation is neither a sufficient
prerequisite for CTL differentiation (MacDonald &
Lees, 1980; Raulet & Bevan, 1982; Kanagawa,
1983), nor is it necessarily followed by cytotoxic
activity (R6llinghoff, 1975).
Considering the pronounced proliferation of
lymphocytes in all examined lymph nodes, regional
and distal ones, and the absence of cytotoxic
activity in distal nodes it is tempting to speculate
that the presence of killer T cells in the ipsilateral
lymph nodes may be a consequence of the meta-
static seeding which beyond Days 9-12 is most
pronounced in these nodes. Decrease in prolifer-
ative activity might be due to the direct suppressive
influence of metastatic tumour cells since the P-815
tumour cell and its subcellular components have
indeed been found to suppress immune reactivity inPROLIFERATION OF LYMPHOCYTES DURING TUMOUR DEVELOPMENT 483
both a specific and a non-specific way (Syrjanen,
1980, Dye & North, 1981; Bertschmann & Liischer,
1983).
The most striking result of the present study was
the marked B cell reaction. In the rat tumour
model (Jones et al., 1978) B cell stimulation was
also described in the form of emerging germinal
centers and plasma cell formation. However, these
morphological signs of B cell responsiveness were
paralleled at later stages of tumour development by
the appearance of circulating antibody, whereas so
far the P-815 tumour could not be shown to
stimulate a humoral antibody response. Manson et
al. (1977) reported that P-815 tumour cells prolifer-
ating in the peritoneal cavity of syngeneic DBA/2
mice were coated with antibody of the IgM class; a
similar observation was made neither with our P-
815 cell line (M.B. unpublished results) nor with the
line used by Biddison & Palmer (1977). The
presence of an alien H-2 specificity (H-2.15) on P-
815 cells has been described by Garrido et al.
(1977). However, the P-815 line used in the present
study lacks this foreign antigen (Clemetson et al.,
1981) so that antibody formation against MHC
class I antigens by some P-815 tumour lines could
explain the discrepancy between our results and
those of Manson et al. (1977).
An early proliferative reaction of medullary
lymphocytic cells on Days 2 to 3 is typical for an
anamnestic B cell response (Burki et al., 1974). In
the examined tumour this could be due to tumour
cell-associated C-type particles. Indeed P-815 cells
infrequently carry C-type particles (M.B.
unpublished results), although they are described to
be free of either Gross leukemia-related antigens
(Green, 1982) or Friend Moloney-Rauscher virus-
related surface structures (Gomard et al., 1974).
As the methods applied in the present study
cannot discriminate between specific tumour-
directed and polyclonal stimulation, the question of
the specificity of the B cell response remains as yet
unanswered. It has indeed been described that
cloned helper T cells are able to polyclonally
activate B cells (Glasebrook et al., 1981). So the
possibility exists that B lymphocytes are activated
by the proliferating tumour cells in a non specific
manner via the stimulation of helper T cells.
Studies concerning secretion and specificity of B
cell products will help to elucidate the relative role
which B and T cells play in the tumour directed
immune reaction.
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